Asaf Weksler
Asaf joined Sphera in 2025 as an Investment Analyst, specializing in real estate and infrastructure. Before joining Sphera, Asaf spent six years in the Budget Department of Israel’s Ministry of Finance, where he served as Head of the Housing and Real Estate Sector and previously worked as a Macro Analyst. Earlier in his career, he
Matan Davidyan
Matan joined Sphera in 2025 as an Equity Analyst. Prior to joining Sphera, he covered a broad range of Israeli companies at a hedge fund and previously held roles in the defense sector. Matan holds a B.A. in Economics and Management from the Open University of Israel, graduating with honors.
Geula Schwartz
Geula joined Sphera in 2006 as a Senior Analyst and was part of the initiation of the Sphera Healthcare Fund. She has over 18 years of experience in analyzing drug development, competitive analysis, and financial modeling. Prior to joining Sphera, Geula held a financial consulting position. Geula holds an MSc in Economics from Tel Aviv University
Avishai Fort
Avishai joined Sphera in 2021 and has over eight years of experience in equity research and analysis. He focuses on several sectors, including digital advertising, consumer internet, and consumer services. Prior to joining Sphera, Avishai served as a Managing Advisor at Giza Singer Even (GSE) Consulting & Advisory, where he contributed to major projects such
Hagai Schor
Hagai is a seasoned executive with a multidisciplinary background at the intersection of business and pharmaceuticals. With over two decades of experience, he is currently part of the team managing Scientific and Clinical Research at Sphera Global Healthcare Fund & Biotech Fund. Prior to joining Sphera, Hagai served as VP of New Ventures & Business Development
Dr. Amit Drach
Amit joined Sphera in 2011 as a Senior Analyst and Co-Portfolio Manager. He brings over 15 years of experience in analyzing drug development, conducting market research, competitive analysis, and financial modeling. Prior to joining Sphera, Amit held several roles in the life sciences industry, including: Business Development Manager at ATI Technological Incubator, where he managed deal
